The Labetalol Hydrochloride Injectio, cataloged under National Stock Number 6505-01-257-9990, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxo Wellcome Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 5 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-257-9990 |
| Primary Part Number | NDC00173-0350-57 |
| Item Name | Labetalol Hydrochloride Injectio |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxo Wellcome Inc |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 40.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Protective Storage Feature | SUBJECT TO DAMAGE BY FREEZING |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC00143-9623-01 | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00173-0350-57 PRIMARY | Glaxo Wellcome Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00085-0362-06 | 5/9 Secondary reference Schering-Plough Corporation |
| NORMODYNE | 5/9 Secondary reference Schering-Plough Corporation |
| TRANDATE | 5/1 Secondary reference Glaxo Wellcome Inc |
| TRANDATE INJECTION | 5/1 Secondary reference Glaxo Wellcome Inc |
| NORMODYNE INJECTION | 5/9 Secondary reference Schering-Plough Corporation |
NSN 6505-01-257-9990 is a Labetalol Hydrochloride Injectio, manufactured by Glaxo Wellcome Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-257-9990 has 2 manufacturer part numbers on file: NDC00143-9623-01 (Hikma Pharmaceuticals Usa Inc.), NDC00173-0350-57 (Glaxo Wellcome Inc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-285-0171. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00173-0350-57: Administration: INTRAVENOUS; Primary Container Content Quantity: 40.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL, MULTIPLE DOSE. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.